Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emyal Alyaydin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|January 11, 2025
In the Twilight of Evidence: Is Bypass Surgery Still on the Table for Cardiac Allograft Vasculopathy?Emyal Alyaydin, Andreas J Flammer
Cardiology Journal|February 14, 2020
Predisposing factors for late mortality in heart transplant patientsEmyal Alyaydin, Henryk Welp, Holger Reinecke, et al.
Medicine|October 18, 2022
Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reductionEmyal Alyaydin, Holger Reinecke, Izabela Tuleta, et al.
The American Journal of Cardiology|June 25, 2023
Septal Microsphere Embolization in Hypertrophic Obstructive CardiomyopathyEmyal Alyaydin, Rolf Alexander Jánosi, Peter Luedike, et al.
Journal of Clinical Medicine|April 28, 2023
Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal HypertrophyEmyal Alyaydin, Julia Kirsten Vogel, Peter Luedike, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 7, 2022
Permanent pacing in a very long-term follow-up after orthotopic heart transplantation: A matter of when or why?Emyal Alyaydin, Christian Pogoda, Angelo Dell'Aquila, et al.
Cardiology Journal|April 4, 2022
Cardiac allograft vasculopathy in a long-term follow-up after heart transplantation: Role of remnant cholesterol in residual inflammationEmyal Alyaydin, Christian Pogoda, Angelo Dell Aquila, et al.
Heart Failure Reviews|February 13, 2025
Tricuspid regurgitation after heart transplantation: where innovation and intervention are in hibernationEmyal Alyaydin, Alexander Gotschy, Danaë Parianos, et al.
ESC Heart Failure|October 28, 2022
To hit a home run as a heterotopic heart recipient-living with two hearts for over three decades: a case reportEmyal Alyaydin, Christian Pogoda, Henryk Welp, et al.
Heart Failure Reviews|November 8, 2024
Sodium-glucose co-transporter 2 inhibitors in left ventricular assist device and heart transplant recipients: a mini-reviewEmyal Alyaydin, Danaë Parianos, Julia Hermes-Laufer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|January 11, 2025
In the Twilight of Evidence: Is Bypass Surgery Still on the Table for Cardiac Allograft Vasculopathy?Emyal Alyaydin, Andreas J Flammer
Cardiology Journal|February 14, 2020
Predisposing factors for late mortality in heart transplant patientsEmyal Alyaydin, Henryk Welp, Holger Reinecke, et al.
Medicine|October 18, 2022
Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reductionEmyal Alyaydin, Holger Reinecke, Izabela Tuleta, et al.
The American Journal of Cardiology|June 25, 2023
Septal Microsphere Embolization in Hypertrophic Obstructive CardiomyopathyEmyal Alyaydin, Rolf Alexander Jánosi, Peter Luedike, et al.
Journal of Clinical Medicine|April 28, 2023
Sex-Related Differences among Adults with Hypertrophic Obstructive Cardiomyopathy Undergoing Transcoronary Ablation of Septal HypertrophyEmyal Alyaydin, Julia Kirsten Vogel, Peter Luedike, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|June 7, 2022
Permanent pacing in a very long-term follow-up after orthotopic heart transplantation: A matter of when or why?Emyal Alyaydin, Christian Pogoda, Angelo Dell'Aquila, et al.
Cardiology Journal|April 4, 2022
Cardiac allograft vasculopathy in a long-term follow-up after heart transplantation: Role of remnant cholesterol in residual inflammationEmyal Alyaydin, Christian Pogoda, Angelo Dell Aquila, et al.
Heart Failure Reviews|February 13, 2025
Tricuspid regurgitation after heart transplantation: where innovation and intervention are in hibernationEmyal Alyaydin, Alexander Gotschy, Danaë Parianos, et al.
ESC Heart Failure|October 28, 2022
To hit a home run as a heterotopic heart recipient-living with two hearts for over three decades: a case reportEmyal Alyaydin, Christian Pogoda, Henryk Welp, et al.
Heart Failure Reviews|November 8, 2024
Sodium-glucose co-transporter 2 inhibitors in left ventricular assist device and heart transplant recipients: a mini-reviewEmyal Alyaydin, Danaë Parianos, Julia Hermes-Laufer, et al.
Pageof 2